Li-Fraumeni syndrome heterogeneity

被引:24
作者
Gargallo, P. [1 ]
Yanez, Y. [2 ]
Segura, V. [2 ]
Juan, A. [1 ]
Torres, B. [1 ]
Balaguer, J. [1 ]
Oltra, S. [3 ,4 ]
Castel, V. [1 ]
Canete, A. [1 ]
机构
[1] La Fe Hosp, Pediat Oncol, Av Fernando Abril Martorell 106, Valencia 46026, Spain
[2] La Fe Hosp, Clin & Translat Oncol Res Grp, Valencia, Spain
[3] La Fe Hosp, Genet Unit, Valencia, Spain
[4] Univ Valencia, Genet Dept, Valencia, Spain
关键词
Li-Fraumeni syndrome; Genotype; Phenotype; Epigenome; Pediatrics; TP53 MUTATION CARRIERS; GAIN-OF-FUNCTION; CANCER PREDISPOSITION; MUTANT P53; RELATIVE FREQUENCY; TELOMERE LENGTH; WIDE SPECTRUM; TUMOR ONSET; GERMLINE; FAMILIES;
D O I
10.1007/s12094-019-02236-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clinical variability is commonly seen in Li-Fraumeni syndrome. Phenotypic heterogeneity is present among different families affected by the same pathogenic variant in TP53 gene and among members of the same family. However, causes of this huge clinical spectrum have not been studied in depth. TP53 type mutation, polymorphic variants in TP53 gene or in TP53-related genes, copy number variations in particular regions, and/or epigenetic deregulation of TP53 expression might be responsible for clinical heterogeneity. In this review, recent advances in the understanding of genetic and epigenetic aspects influencing Li-Fraumeni phenotype are discussed.
引用
收藏
页码:978 / 988
页数:11
相关论文
共 105 条
  • [91] Vahteristo P, 2001, CANCER RES, V61, P5718
  • [92] Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition
    Valdez, Jessica M.
    Nichols, Kim E.
    Kesserwan, Chimene
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (04) : 539 - 552
  • [93] Varley Jenny, 2003, Methods Mol Biol, V222, P117
  • [94] The rebel angel: mutant p53 as the driving oncogene in breast cancer
    Walerych, Dawid
    Napoli, Marco
    Collavin, Licio
    Del Sal, Giannino
    [J]. CARCINOGENESIS, 2012, 33 (11) : 2007 - 2017
  • [95] To be, or not to be: functional dilemma of p53 metabolic regulation
    Wang, Shang-Jui
    Gu, Wei
    [J]. CURRENT OPINION IN ONCOLOGY, 2014, 26 (01) : 78 - 85
  • [96] Functional interaction of p53 and BLM DNA helicase in apoptosis
    Wang, XW
    Tseng, A
    Ellis, NA
    Spillare, EA
    Linke, SP
    Robles, AI
    Seker, H
    Yang, Q
    Hu, P
    Beresten, S
    Bemmels, NA
    Garfield, S
    Harris, CC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) : 32948 - 32955
  • [97] miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress
    Xiao, Jiening
    Lin, Huixian
    Luo, Xiaobin
    Luo, Xiaoyan
    Wang, Zhiguo
    [J]. EMBO JOURNAL, 2011, 30 (03) : 524 - 532
  • [98] Xie Yao, 2017, Zhongguo Dang Dai Er Ke Za Zhi, V19, P1263
  • [99] Heterogeneity of Li-Fraumeni Syndrome links to unequal gain-of-function effects of p53 mutations
    Xu, Jie
    Qian, Jin
    Hu, Ye
    Wang, Jilin
    Zhou, Xiaolin
    Chen, Haoyan
    Fang, Jing-Yuan
    [J]. SCIENTIFIC REPORTS, 2014, 4
  • [100] Identification and characterization of a novel germline p53 mutation in a patient with glioblastoma and colon cancer
    Yamada, Hidetaka
    Shinmura, Kazuya
    Yamamura, Yasuhiro
    Kurachi, Kiyotaka
    Nakamura, Toshio
    Tsuneyoshi, Toshihiro
    Yokota, Naoki
    Mackawa, Masato
    Sugimura, Haruhiko
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (04) : 973 - 976